New chief medical officer will help shape the EMA's public image

The European Medicines Agency has appointed Danish national Steffen Thirstrup as chief medical officer, a role considered to be the “medical voice” of the EU’s regulatory work within pharmaceuticals.

Steffen Thirstrup, newly appointed chief medical officer of the EMA | Photo: EMA / PR

Yesterday, Steffen Thirstrup was announced as the new chief medical officer of the European Medicines Agency (EMA), and he is now set to return to the EU’s regulatory work.

The new appointee has previously led the division for medicines assessment and clinical trials at the Danish Health Authority, and has also served in a number of positions at the EMA, including as the Danish member of the agency’s expert committee, the CHMP.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs